Articles From: Tranzyme Pharma and Ocera Therapeutics Announce Merger Agreement to Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of MEMSIC, Inc. Shareholders


2013/4/23
$20M Committed PIPE Financing to Close With Merger RESEARCH TRIANGLE PARK, N.C. and SAN DIEGO, April 23, 2013 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) ("Tranzyme"), a biopharmaceutical company focused on discovering, developing and commercializing novel, mechanism-based therapeutics, and Ocera Therapeutics, Inc. ("Ocera"), a privately held biopharmaceutical company developing novel therapeutics for liver diseases, today announced that they have entered into a definitive agreement under which Ocera will merge with a subsidiary of Tranzyme in an all-stock transaction.
Sign-up for Tranzyme Pharma and Ocera Therapeutics Announce Merger Agreement investment picks
2013/4/23
Discovery Air Inc. announces results for the quarter and year ended January 31, 2013.
Sign-up for Discovery Air Inc. announces results for the quarter and year ended January 31, 2013. investment picks
2013/4/23
For the past few decades, IGT has made more millionaires than any other gaming manufacturer.
Sign-up for IGT's American Idol® Encore creates another millionaire at Kewadin Casino St. Ignace in St. Ignace, Michigan investment picks
2013/4/23
CARLSBAD, Calif.
Sign-up for Callaway Golf Declares Quarterly Dividends investment picks
2013/4/23
--Edwards misses expectations as sales of its Sapien heart-valve stumble in the U.S. --Some customers are questioning the profitability and cost of the devices, Edwards says --Company lowers 2013 sales guidance range to between $2 billion and $2.1 billion (Updated throughout to add details and company comment.) By Joseph Walker Edwards Lifesciences Corp.
Sign-up for UPDATE: Edwards Lifesciences Reports Disappointing Sales, Outlook investment picks
2013/4/23
--Schwab website hit by denial of service attack --Issue affected clients for approximately one hour and forty minutes --Company says web access "largely restored." (Adds information on denial of service attack throughout.) By Brett Philbin Customers of Charles Schwab Corp.
Sign-up for 2nd UPDATE: Schwab Website Disrupted by Denial-of-Service Attack investment picks
2013/4/23
ARLINGTON, Va.
Sign-up for Arlington Asset Investment Corp. Announces Pricing of Senior Notes Offering investment picks
2013/4/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0868699001&sourceType=1 http://www.ccnmatthews.com/logos/20101117-rain2.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for Rainmaker Entertainment Reveals Ratchet and Clank(R) as Its Next Feature Length Film investment picks
2013/4/23
--Enterprise licenses 29% of first-quarter bookings --Employee count down 800 from beginning of first quarter --Virtual network product VMwareNSX to appear in second half By Steven D.
Sign-up for UPDATE: VMware Reports 'Solid Start' to Year, But Outlook Weighs on Stock investment picks
2013/4/23
-- AT&T first-quarter profit grew 3.2% on revenue drop of 1.5% --Drop in smartphone sales boost wireless service margins --Backs 2013 revenue and per-share earnings guidance (Adds executive comments and details throughout.) By Thomas Gryta AT&T Inc. (T) said its first-quarter earnings grew 3.2% as a seasonal decline in smartphone sales helped raise the profitability of its wireless service business, even as total revenue had a larger-than-expected drop.
Sign-up for 2nd UPDATE: AT&T Earnings Rise 3.2%, Helped By Wireless Profits investment picks
2013/4/23
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Power-One, Inc. (“Power-One” or the “Company”) (NASDAQ: PWER) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to ABB (NYSE: ABB) in an all-cash deal valued at approximately $1 billion.
Sign-up for Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Power-One, Inc. (PWER) investment picks
2013/4/23
The Law Offices of Todd M.
Sign-up for Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline in the Class Action Lawsuit against Affymax, Inc. investment picks
2013/4/23
Apple Inc.’s just-released earnings show quite a contrast between the recent past and the near future.
Sign-up for How to play Apple's beauty and the beast earnings investment picks
2013/4/23
LOS ANGELES, April 23, 2013 (GLOBE NEWSWIRE) -- Glancy Binkow & Goldberg LLP, representing investors of Harvest Natural Resources Inc. ("Harvest" or the "Company") (NYSE:HNR) , has filed a class action lawsuit in the United States District Court for the Southern District of Texas on behalf of a class (the "Class") comprising all purchasers of Harvest securities between May 7, 2010 and March 18, 2013, inclusive (the "Class Period"). The Complaint alleges that throughout the Class Period the Company and certain of its executive officers issued false and/or misleading statements or failed to disclose material adverse facts concerning the Company's financial performance and prospects.
Sign-up for Glancy Binkow & Goldberg LLP Files Class Action Lawsuit Against Harvest Natural Resources Inc. -- HNR investment picks
2013/4/23
Nationalized Spanish bank Bankia SA said Tuesday it has completed the purchase of a 50% stake in Aseval for 608 million euros ( $791 million ) from U.K. insurer Aviva PLC (AV.LN). In a filing to the Spanish stock market regulator, the company said the operation, which was announced in December, is part of its 2012-2015 strategic plan to bolster its bancassurance business.
Sign-up for Bankia Buys 50% Stake in Aseval for EUR608 Million From Aviva investment picks
2013/4/23
Newcastle Investment Corp.
Sign-up for Newcastle Schedules First Quarter 2013 Earnings Release and Conference Call investment picks
2013/4/23
Kansas City Southern (“KCS”) (NYSE:KSU) announced today that its wholly-owned subsidiary, Kansas City Southern de México, S.A. de C.V. (“KCSM”), a Mexican corporation, has received, pursuant to its previously announced cash tender offers and related consent solicitations (the “Offers”) for its 8% Senior Notes due 2018 and its 6.625% Senior Notes due 2020 (collectively, the “Any and All Notes”), the requisite consents to adopt the proposed amendments to the indentures governing the Any and All Notes.
Sign-up for KCS Announces Receipt of Requisite Consents and Early Results of Tender Offers and Consent Solicitations investment picks
2013/4/23
-- Amgen's profit jumps 21%, bolstered by a lower tax rate --Revenue falls short of analysts' expectations --International sales up 8% Amgen Inc.'s (AMGN) first-quarter earnings rose 21% as a significantly lower tax rate offset disappointing sales, especially of its key arthritis and osteoporosis drug.
Sign-up for Amgen Sales Disappoint as Profits Jump 21% investment picks
2013/4/23
Trinidad Drilling Ltd.
Sign-up for Trinidad Drilling Ltd. to release first quarter 2013 results and to hold conference call and webcast investment picks
2013/4/23
SANTIAGO, Chile --Chilean power generator Colbun SA (COLBUN.SN) plans to invest about $3 billion in energy projects that will add around 1,000 megawatts to its portfolio, company President Bernardo Larrain said Tuesday.
Sign-up for Chile Power Generator Colbun Plans $3 Billion in Project Investments investment picks
2013/4/23
Cline announces Annual General Meeting Canada NewsWire About Cline Cline has metallurgical coal property interests in British Columbia and in Colorado, U.S.A. including the 100% interest in the New Elk coking coal mine.
Sign-up for Cline announces Annual General Meeting investment picks
2013/4/23
-- Amgen's profit jumps 21%, bolstered by a lower tax rate --Revenue falls short of analysts' expectations --International sales up 8% (Adds details and company comment beginning in first paragraph.) By Joseph Walker Amgen Inc.'s (AMGN) first-quarter earnings rose 21% as a significantly lower tax rate offset disappointing sales, especially of its key arthritis and osteoporosis drug.
Sign-up for UPDATE: Amgen Sales Disappoint as Profits Jump 21% investment picks
2013/4/23
The global LED market's average compound annual growth will be as high as 33 percent through 2016, according to analyst firm McKinsey & Company.
Sign-up for Dow Corning Sees Projected Global Growth of LED Lighting Linked to Adoption of Advanced Optical Silicones investment picks
2013/4/23
- Rohr Becomes Executive Chairman - PITTSBURGH , April 23, 2013 /PRNewswire/ -- The PNC Financial Services Group, Inc. (NYSE: PNC) announced today that William S.
Sign-up for William S. Demchak Succeeds James E. Rohr as PNC Chief Executive Officer investment picks
2013/4/23
GLENWOOD, Ill.
Sign-up for Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Second Quarter 2013 Results investment picks
2013/4/23
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Aerosonic Corp.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Aerosonic Corp. Shareholders investment picks
2013/4/23
RIVERSIDE, Calif., April 23, 2013 (GLOBE NEWSWIRE) -- Provident Financial Holdings, Inc. (Nasdaq:PROV) , the holding company for Provident Savings Bank, F.S.B., today announced that it will host a conference call for institutional investors and bank analysts on Friday, April 26, 2013 at 9:00 a.m. (Pacific) to discuss its financial results.
Sign-up for Provident Financial Holdings to Host Earnings Release Conference Call investment picks
2013/4/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010174&ProfileId=051205&sourceType=1 SANTA BARBARA, CA --
Sign-up for StreamTrack Announces Operating Results for Second Quarter Fiscal 2013 investment picks
2013/4/23
Kirby McInerney LLP is investigating potential claims against the Board of Directors of MEMSIC, Inc. (“MEMS” or the “Company”) (NASDAQ: MEMS) related to the proposed acquisition of the Company by IDG-Accel China Capital II, L.P. and Affiliates (“IDG”). Under the terms of the proposal, IDG will acquire all of the outstanding common stock of MEMSIC for $4.225 per share in cash, for a total transaction value of approximately $88.5 million.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of MEMSIC, Inc. Shareholders investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Tranzyme Pharma and Ocera Therapeutics Announce Merger Agreement to Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of MEMSIC, Inc. Shareholders
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity